Recent findings suggest that IL-4 neutralization can enhance anti-tumor immunity by reducing the generation of immunosuppressive M2 macrophages and myeloid-derived suppressor cells, while increasing tumor-specific cytotoxic T lymphocytes, thus delaying tumor progression [106]. The gene discussed is IL4; the disease is neoplasm.